FdaApplication
NDA 213026
Identifiers
- fda_app_no: NDA213026
Properties
| Property | Value |
|---|---|
| applicant_name | SAREPTA THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2021-02-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMONDYS 45 | CASIMERSEN | 100MG/2ML (50MG/ML) | SOLUTION;INTRAVENOUS |
1 product